Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SAMRAT PHARMA   ACTAVIS
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
ACTAVIS
Dec-18
SAMRAT PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,25016,126-   
Low Rs33210,818-   
Sales per share (Unadj.) Rs1,005.33,955.8-  
Earnings per share (Unadj.) Rs53.8-1,274.2-  
Cash flow per share (Unadj.) Rs55.9416.9-  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs204.316,315.7-  
Shares outstanding (eoy) m3.09332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.83.4 23.1%   
Avg P/E ratio x14.7-10.6 -139.0%  
P/CF ratio (eoy) x14.132.3 43.8%  
Price / Book Value ratio x3.90.8 468.8%  
Dividend payout %1.90-   
Avg Mkt Cap Rs m2,4444,480,758 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m110-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m3,1061,315,689 0.2%  
Other income Rs m525,160 0.0%   
Total revenues Rs m3,1111,340,849 0.2%   
Gross profit Rs m23934,478 0.7%  
Depreciation Rs m6562,428 0.0%   
Interest Rs m1275,923 0.0%   
Profit before tax Rs m225-578,713 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m59-7,334 -0.8%   
Profit after tax Rs m166-423,784 -0.0%  
Gross profit margin %7.72.6 293.9%  
Effective tax rate %26.21.3 2,066.4%   
Net profit margin %5.4-32.2 -16.6%  
BALANCE SHEET DATA
Current assets Rs m986539,627 0.2%   
Current liabilities Rs m528477,372 0.1%   
Net working cap to sales %14.84.7 312.0%  
Current ratio x1.91.1 165.4%  
Inventory Days Days820 41.1%  
Debtors Days Days60266 907.9%  
Net fixed assets Rs m175148,929 0.1%   
Share capital Rs m310-   
"Free" reserves Rs m6010-   
Net worth Rs m6315,426,601 0.0%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m1,1628,483,012 0.0%  
Interest coverage x19.3-6.6 -291.2%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x2.70.2 1,724.4%   
Return on assets %15.4-4.1 -375.0%  
Return on equity %26.3-7.8 -337.3%  
Return on capital %37.6-4.8 -777.4%  
Exports to sales %4.10-   
Imports to sales %83.30-   
Net fx Rs m-2,4600-   
CASH FLOW
From Operations Rs m-94470,046 -0.0%  
From Investments Rs m-30258,229 -0.0%  
From Financial Activity Rs m96-806,740 -0.0%  
Net Cashflow Rs m-28-78,073 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SAMRAT PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SAMRAT PHARMA With: IPCA LABS  GUFIC BIOSCIENCE  ALPA LAB  FREDUN PHARMA  LUPIN  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.